ArticleDigestive diseases and sciences2025
Trends in Mortality Caused by Hepatitis C Virus in the United States Population: A Retrospective Cross-Sectional Study Using the CDC WONDER Database.
Article in Digestive diseases and sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDespite the advancements in the diagnostics and therapeutics of hepatitis C, the mortality trends from the hepatitis C virus (HCV) have remained a national burden. We aimed to investigate the mortality trends of hepatitis viruses specifically hepatitis C virus in the United States population from 1999 to 2023.
methodsIn this retrospective analysis, spanning from 1999 to 2023, we examined mortality trends using national mortality datasets among individuals infected with any hepatitis virus. We aimed to analyze these trends in mortality among United States (US) residents by demographic characteristics including age, gender, race/ethnicity, and geographic characteristics like urbanization and census region. The national mortality data from the multiple causes of death files in the CDC WONDER Database were queried by applying the ICD-10 codes as B16-B19 to identify death certificates listing viral hepatitis as one of the listed causes. Trends in age-adjusted mortality rate (AAMR) were assessed and results were expressed as annual percentage changes (APC), average APC, and 95% confidence intervals (CI).
resultsThe crude mortality rate for HCV from 1999 to 2023 was found to be 4.66 per 100,000 US population and AAMR was 4.07 per 100,000 US population. Mortality rates for HCV were found to be highest for the male gender, age group 55-74 years, American Indians or Alaskan Natives, West US Census Region, and Medium to small metropolitan areas (although non-metropolitan areas equally showed upgoing trends as high as the medium to small metropolitan areas, with AAPC of + 4.61 and + 4.70 respectively). Geographically, states in the top 90th percentile for HCV-associated mortality included the District of Columbia, Oklahoma, Oregon, New Mexico, Washington, and California.
conclusionOur study highlights key demographic and geographic disparities in HCV mortality which is the most prevalent among all hepatitis viruses in the United States, underscoring the urgent need for targeted interventions.
Indexed as
Identifiers
40531259What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.